BRAF and MEK resistance in melanoma

被引：0
|
作者：
Herlyn, Meenhard
Villanueva, Jessie
机构：
来源：
CLINICAL CANCER RESEARCH | 2012年 / 18卷 / 10期
关键词：
D O I：
10.1158/1078-0432.MECHRES-IA8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA8
引用
收藏
页数：2
相关论文
共 50 条
  • [31] BRAF and MEK Inhibitors Offer Good News in Melanoma
    不详
    CANCER DISCOVERY, 2012, 2 (07)
  • [32] Sarcoidosis related to checkpoint and BRAF/MEK inhibitors in melanoma
    Rubio-Rivas, Manuel
    Moreira, Catarina
    Marcoval, J.
    AUTOIMMUNITY REVIEWS, 2020, 19 (08)
  • [33] Integrating BRAF/MEK inhibitors into combination therapy for melanoma
    K S M Smalley
    K T Flaherty
    British Journal of Cancer, 2009, 100 : 431 - 435
  • [34] Recent advances in the treatment of melanoma with BRAF and MEK inhibitors
    Munoz-Couselo, Eva
    Soberino Garcia, Jesus
    Manuel Perez-Garcia, Jose
    Ortega Cebrian, Vanesa
    Cortes Castan, Javier
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (15)
  • [35] BRAF/MEK inhibitor rechallenge in advanced melanoma patients
    Van Not, Olivier J.
    van den Eertwegh, Alfons J. M.
    Haanen, John B.
    van Rijn, Rozemarijn S.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot, Jan Willem W. B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Bloem, Manja
    Piersma, Djura
    Stevense-den Boer, Marion
    Verheijden, Rik J.
    van der Veldt, Astrid A. M.
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    CANCER, 2024, 130 (09) : 1673 - 1683
  • [36] A second chance for success with BRAF and MEK inhibitors in melanoma
    Paulson, Kelly G.
    Thompson, John A.
    LANCET ONCOLOGY, 2017, 18 (04): : 418 - 419
  • [37] Integrating BRAF/MEK inhibitors into combination therapy for melanoma
    Smalley, K. S. M.
    Flaherty, K. T.
    BRITISH JOURNAL OF CANCER, 2009, 100 (03) : 431 - 435
  • [38] Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
    Flaherty, Keith T.
    Infante, Jeffery R.
    Daud, Adil
    Gonzalez, Rene
    Kefford, Richard F.
    Sosman, Jeffrey
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Ibrahim, Nageatte
    Kudchadkar, Ragini
    Burris, Howard A., III
    Falchook, Gerald
    Algazi, Alain
    Lewis, Karl
    Long, Georgina V.
    Puzanov, Igor
    Lebowitz, Peter
    Singh, Ajay
    Little, Shonda
    Sun, Peng
    Allred, Alicia
    Ouellet, Daniele
    Kim, Kevin B.
    Patel, Kiran
    Weber, Jeffrey
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1694 - 1703
  • [39] Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma
    Cann, Christopher G.
    Tillman, Benjamin F.
    Davis, Elizabeth J.
    Johnson, Douglas B.
    ONCOLOGIST, 2019, 24 (11): : 1495 - 1496
  • [40] TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors
    de Oliveira, Erica Aparecida
    Chauhan, Jagat
    da Silva, Julia Rezende
    da Costa Carvalho, Larissa Anastacio
    Dias, Diogo
    de Carvalho, Danielle Goncalves
    Masao Watanabe, Luis Roberto
    Rebecca, Vito W.
    Mills, Gordon
    Lu, Yiling
    Felipe da Silva, Aloisio Souza
    Lopes Consolaro, Marcia Edilaine
    Herlyn, Meenhard
    Possik, Patricia A.
    Goding, Colin R.
    Maria-Engler, Silvya Stuchi
    PHARMACOLOGICAL RESEARCH, 2021, 173
12345